Fractional Laser Ablation for the Cutaneous Delivery of Triamcinolone Acetonide from Cryomilled Polymeric Microparticles: Creating Intraepidermal Drug Depots

Molecular Pharmaceutics

Volumn 13, Issue 2, 2016, Pages 500-511

  Singhal, Mayank ^a   Del Río Sancho, Sergio ^a   Sonaje, Kiran ^a   Kalia, Yogeshvar N ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

cryomilling; fractional laser ablation; keloid; microparticle; skin

Indexed keywords

DYE; FLUORESCEIN; NILE; NILE RED DYE; POLYMER; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; NANOPARTICLE;

ANALYTIC METHOD; ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CUTANEOUS DRUG ADMINISTRATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; ERBIUM YAG LASER; FREEZING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IN VITRO STUDY; LASER SURGERY; POLYMERIZATION; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SKIN FUNCTION; SKIN PERMEABILITY; SUSPENSION; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ULTRAVIOLET SPECTROSCOPY; X RAY POWDER DIFFRACTION; ANIMAL; CHEMISTRY; DRUG EFFECTS; LOW LEVEL LASER THERAPY; PIG; SKIN;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTI-INFLAMMATORY AGENTS; DRUG DELIVERY SYSTEMS; LASER THERAPY; NANOPARTICLES; POLYMERS; SKIN; SWINE; TRIAMCINOLONE ACETONIDE;

EID: 84957309693     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/acs.molpharmaceut.5b00711     Document Type: Article

References (52)

1. Naik, A.; Kalia, Y. N.; Guy, R. H. Transdermal drug delivery: overcoming the skin's barrier function Pharm. Sci. Technol. Today 2000, 3, 318-326 10.1016/S1461-5347(00)00295-9
2. Gratieri, T.; Alberti, I.; Lapteva, M.; Kalia, Y. N. Next generation intra- and transdermal therapeutic systems: Using non- and minimally-invasive technologies to increase drug delivery into and across the skin Eur. J. Pharm. Sci. 2013, 50, 609-622 10.1016/j.ejps.2013.03.019
3. Taudorf, E. H.; Lerche, C. M.; Vissing, A. C.; Philipsen, P. A.; Hannibal, J.; D'Alvise, J.; Hansen, S. H.; Janfelt, C.; Paasch, U.; Anderson, R. R.; Haedersdal, M. Topically applied methotrexate is rapidly delivered into skin by fractional laser ablation Expert Opin. Drug Delivery 2015, 12, 1-11 10.1517/17425247.2015.1031216
4. Erlendsson, A. M.; Taudorf, E. H.; Eriksson, A. H.; Haak, C. S.; Zibert, J. R.; Paasch, U.; Anderson, R. R.; Haedersdal, M. Ablative fractional laser alters biodistribution of ingenol mebutate in the skin Arch. Dermatol. Res. 2015, 307, 515 10.1007/s00403-015-1561-3
5. Yu, J.; Bachhav, Y. G.; Summer, S.; Heinrich, A.; Bragagna, T.; Bohler, C.; Kalia, Y. N. Using controlled laser-microporation to increase transdermal delivery of prednisone J. Controlled Release 2010, 148, 71-73 10.1016/j.jconrel.2010.07.032
6. Bachhav, Y. G.; Summer, S.; Heinrich, A.; Bragagna, T.; Bohler, C.; Kalia, Y. N. Effect of controlled laser microporation on drug transport kinetics into and across the skin J. Controlled Release 2010, 146, 31-36 10.1016/j.jconrel.2010.05.025
7. Bachhav, Y. G.; Heinrich, A.; Kalia, Y. N. Controlled intra- and transdermal protein delivery using a minimally invasive Erbium:YAG fractional laser ablation technology Eur. J. Pharm. Biopharm. 2013, 84, 355-364 10.1016/j.ejpb.2012.11.018
8. Weiss, R.; Hessenberger, M.; Kitzmüller, S.; Bach, D.; Weinberger, E. E.; Krautgartner, W. D.; Hauser-Kronberger, C.; Malissen, B.; Boehler, C.; Kalia, Y. N.; Thalhamer, J.; Scheiblhofer, S. Transcutaneous vaccination via laser microporation J. Controlled Release 2012, 162, 391-399 10.1016/j.jconrel.2012.06.031
9. Terhorst, D.; Fossum, E.; Baranska, A.; Tamoutounour, S.; Malosse, C.; Garbani, M.; Braun, R.; Lechat, E.; Crameri, R.; Bogen, B.; Henri, S.; Malissen, B. Laser-Assisted Intradermal Delivery of Adjuvant-Free Vaccines Targeting XCR1+ Dendritic Cells Induces Potent Antitumoral Responses J. Immunol. 2015, 194, 5895-5902 10.4049/jimmunol.1500564
10. Yu, J.; Kalaria, D. R.; Kalia, Y. N. Erbium:YAG fractional laser ablation for the percutaneous delivery of intact functional therapeutic antibodies J. Controlled Release 2011, 156, 53-59 10.1016/j.jconrel.2011.07.024
11. Zech, N. H.; Murtinger, M.; Uher, P. Pregnancy after ovarian superovulation by transdermal delivery of follicle-stimulating hormone Fertil. Steril. 2011, 95, 2784-2785 10.1016/j.fertnstert.2011.03.073
12. Teutonico, D.; Montanari, S.; Ponchel, G. Leuprolide acetate: pharmaceutical use and delivery potentials Expert Opin. Drug Delivery 2012, 9, 343-354 10.1517/17425247.2012.662484
13. Gauglitz, G. G.; Korting, H. C.; Pavicic, T.; Ruzicka, T.; Jeschke, M. G. Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies Mol. Med. 2011, 17, 113-125 10.2119/molmed.2009.00153
14. Peacock, E. E., Jr.; Madden, J. W.; Trier, W. C. Biologic basis for the treatment of keloids and hypertrophic scars South. Med. J. 1970, 63, 755-760 10.1097/00007611-197007000-00002
15. Mancini, R. E.; Quaife, J. V. Histogenesis of experimentally produced keloids J. Invest. Dermatol. 1962, 38, 143-181 10.1038/jid.1962.29
16. O'Sullivan, S. T.; O'Shaughnessy, M.; O'Connor, T. P. Aetiology and management of hypertrophic scars and keloids Ann. R. Coll. Surg. Engl. 1996, 78, 168-175
17. Mutalik, S. Treatment of keloids and hypertrophic scars Indian J. Dermatol. Venereol. Leprol. 2005, 71, 3-8 10.4103/0378-6323.13777
18. Juckett, G.; Hartman-Adams, H. Management of keloids and hypertrophic scars Am. Fam. Physician 2009, 80, 253-260
19. Niessen, F. B.; Spauwen, P. H.; Schalkwijk, J.; Kon, M. On the nature of hypertrophic scars and keloids: a review Plast. Reconstr. Surg. 1999, 104, 1435-1458 10.1097/00006534-199910000-00031
20. Diegelmann, R. F.; Bryant, C. P.; Cohen, I. K. Tissue alpha-globulins in keloid formation Plast. Reconstr. Surg. 1977, 59, 418-423 10.1097/00006534-197703000-00018
21. Golladay, E. S. Treatment of keloids by single intraoperative perilesional injection of repository steroid South. Med. J. 1988, 81, 736-738 10.1097/00007611-198806000-00013
22. Sherris, D. A.; Larrabee, W. F., Jr.; Murakami, C. S. Management of scar contractures, hypertrophic scars, and keloids Otolaryngol. Clin. North Am. 1995, 28, 1057-1068
23. Jalali, M.; Bayat, A. Current use of steroids in management of abnormal raised skin scars surgeon: journal of the Royal Colleges of Surgeons of Edinburgh and Ireland 2007, 5, 175-180 10.1016/S1479-666X(07)80045-X
24. Kumar, S.; Singh, R. J.; Reed, A. M.; Lteif, A. N. Cushing's syndrome after intra-articular and intradermal administration of triamcinolone acetonide in three pediatric patients Pediatrics 2004, 113, 1820-1824 10.1542/peds.113.6.1820
25. Finken, M. J.; Mul, D. Cushing's syndrome and adrenal insufficiency after intradermal triamcinolone acetonide for keloid scars Eur. J. Pediatr. 2010, 169, 1147-1149 10.1007/s00431-010-1165-z
26. Teelucksingh, S.; Balkaran, B.; Ganeshmoorthi, A.; Arthur, P. Prolonged childhood Cushing's syndrome secondary to intralesional triamcinolone acetonide Ann. Trop. Paediatr. 2002, 22, 89-91 10.1179/027249302125000229
27. Liu, M. F.; Yencha, M. Cushing's syndrome secondary to intralesional steroid injections of multiple keloid scars Otolaryngol. - Head Neck Surg. 2006, 135, 960-961 10.1016/j.otohns.2005.04.005
28. Mishra, S. Safe and less painful injection of triamcenolone acetonide into a keloid - a technique J. Plast. Reconstr. Aesthet. Surg. 2010, 63, 205 10.1016/j.bjps.2009.02.077
29. Sabzevari, A.; Adibkia, K.; Hashemi, H.; Hedayatfar, A.; Mohsenzadeh, N.; Atyabi, F.; Ghahremani, M. H.; Dinarvand, R. Polymeric triamcinolone acetonide nanoparticles as a new alternative in the treatment of uveitis: in vitro and in vivo studies Eur. J. Pharm. Biopharm. 2013, 84, 63-71 10.1016/j.ejpb.2012.12.010
30. Birnbaum, D. T.; Kosmala, J. D.; Henthorn, D. B.; Brannon-Peppas, L. Controlled release of β-estradiol from PLAGA microparticles:: The effect of organic phase solvent on encapsulation and release J. Controlled Release 2000, 65, 375-387 10.1016/S0168-3659(99)00219-9
31. Jeong, Y. I.; Song, J. G.; Kang, S. S.; Ryu, H. H.; Lee, Y. H.; Choi, C.; Shin, B. A.; Kim, K. K.; Ahn, K. Y.; Jung, S. Preparation of poly(DL-lactide-co-glycolide) microspheres encapsulating all-trans retinoic acid Int. J. Pharm. 2003, 259, 79-91 10.1016/S0378-5173(03)00207-2
32. Layre, A.-M.; Gref, R.; Richard, J.; Requier, D.; Chacun, H.; Appel, M.; Domb, A. J.; Couvreur, P. Nanoencapsulation of a crystalline drug Int. J. Pharm. 2005, 298, 323-327 10.1016/j.ijpharm.2005.02.039
33. Chen, Z.-K.; Yang, J.-P.; Ni, Q.-Q.; Fu, S.-Y.; Huang, Y.-G. Reinforcement of epoxy resins with multi-walled carbon nanotubes for enhancing cryogenic mechanical properties Polymer 2009, 50, 4753-4759 10.1016/j.polymer.2009.08.001
34. Adibkia, K.; Shadbad, M. R. S.; Nokhodchi, A.; Javadzedeh, A.; Barzegar-Jalali, M.; Barar, J.; Mohammadi, G.; Omidi, Y. Piroxicam nanoparticles for ocular delivery: Physicochemical characterization and implementation in endotoxin-induced uveitis J. Drug Target. 2007, 15, 407-416 10.1080/10611860701453125
35. Tracy, M. A.; Ward, K. L.; Firouzabadian, L.; Wang, Y.; Dong, N.; Qian, R.; Zhang, Y. Factors affecting the degradation rate of poly(lactide-co-glycolide) microspheres in vivo and in vitro Biomaterials 1999, 20, 1057-1062 10.1016/S0142-9612(99)00002-2
36. Anderson, J. M.; Shive, M. S. Biodegradation and biocompatibility of PLA and PLGA microspheres Adv. Drug Delivery Rev. 1997, 28, 5-24 10.1016/S0169-409X(97)00048-3
37. Vert, M.; Mauduit, J.; Li, S. Biodegradation of PLA/GA polymers: increasing complexity Biomaterials 1994, 15, 1209-1213 10.1016/0142-9612(94)90271-2
38. Zidan, A.; Sammour, O.; Hammad, M.; Megrab, N.; Hussain, M.; Khan, M.; Habib, M. Formulation of anastrozole microparticles as biodegradable anticancer drug carriers AAPS PharmSciTech 2006, 7, 38-46 10.1208/pt070361
39. Kurokawa, N.; Ueda, K.; Tsuji, M. Study of microvascular structure in keloid and hypertrophic scars: Density of microvessels and the efficacy of three-dimensional vascular imaging J. Plast. Surg. Hand Surg. 2010, 44, 272-277 10.3109/2000656X.2010.532923
40. Kischer, C. W.; Thies, A. C.; Chvapil, M. Perivascular myofibroblasts and microvascular occlusion in hypertrophic scars and keloids Hum. Pathol. 1982, 13, 819-824 10.1016/S0046-8177(82)80078-6
41. Chokshi, R. J.; Sandhu, H. K.; Iyer, R. M.; Shah, N. H.; Malick, A. W.; Zia, H. Characterization of physico-mechanical properties of indomethacin and polymers to assess their suitability for hot-melt extrusion processs as a means to manufacture solid dispersion/solution J. Pharm. Sci. 2005, 94, 2463-2474 10.1002/jps.20385
42. Gahoi, S.; Jain, G. K.; Tripathi, R.; Pandey, S. K.; Anwar, M.; Warsi, M. H.; Singhal, M.; Khar, R. K.; Ahmad, F. J. Enhanced antimalarial activity of lumefantrine nanopowder prepared by wet-milling DYNO MILL technique Colloids Surf., B 2012, 95, 16-22 10.1016/j.colsurfb.2012.01.047
43. Bachhav, Y. G.; Heinrich, A.; Kalia, Y. N. Using laser microporation to improve transdermal delivery of diclofenac: Increasing bioavailability and the range of therapeutic applications Eur. J. Pharm. Biopharm. 2011, 78, 408-414 10.1016/j.ejpb.2011.03.006
44. Block, L. H.; Patel, R. N. Solubility and dissolution of triamcinolone acetonide J. Pharm. Sci. 1973, 62, 617-621 10.1002/jps.2600620416
45. Behl, C. R.; Block, L. H.; Borke, M. L. Aqueous solubility of 14c-triamcinolone acetonide J. Pharm. Sci. 1976, 65, 429-430 10.1002/jps.2600650329
46. Rohatagi, S.; Hochhaus, G.; Mollmann, H.; Barth, J.; Galia, E.; Erdmann, M.; Sourgens, H.; Derendorf, H. Pharmacokinetic and pharmacodynamic evaluation of triamcinolone acetonide after intravenous, oral, and inhaled administration J. Clin. Pharmacol. 1995, 35, 1187-1193 10.1002/j.1552-4604.1995.tb04045.x
47. Lademann, J.; Richter, H.; Teichmann, A.; Otberg, N.; Blume-Peytavi, U.; Luengo, J.; Weiß, B.; Schaefer, U. F.; Lehr, C.-M.; Wepf, R.; Sterry, W. Nanoparticles-An efficient carrier for drug delivery into the hair follicles Eur. J. Pharm. Biopharm. 2007, 66, 159-164 10.1016/j.ejpb.2006.10.019
48. Mak, W. C.; Patzelt, A.; Richter, H.; Renneberg, R.; Lai, K. K.; Rühl, E.; Sterry, W.; Lademann, J. Triggering of drug release of particles in hair follicles J. Controlled Release 2012, 160, 509-514 10.1016/j.jconrel.2012.04.007
49. Genina, E. A.; Bashkatov, A. N.; Dolotov, L. E.; Maslyakova, G. N.; Kochubey, V. I.; Yaroslavsky, I. V.; Altshuler, G. B.; Tuchin, V. V. Transcutaneous delivery of micro- and nanoparticles with laser microporation J. Biomed. Opt. 2013, 18, 111406 10.1117/1.JBO.18.11.111406
50. Carantino, I.; Florescu, I. P.; Carantino, A. Overview about the keloid scars and the elaboration of a non-invasive, unconventional treatment J. Med. Life 2010, 3, 122-127
51. Hunasgi, S.; Koneru, A.; Vanishree, M.; Shamala, R. Keloid: A case report and review of pathophysiology and differences between keloid and hypertrophic scars J. Oral Maxillofac. Pathol. 2013, 17, 116-120 10.4103/0973-029X.110701
52. Pantec Biosolutions, Laser microporation technology P.L.E.A.S.E.® Platform, http://www.pantec-biosolutions.com/en/technology/laser-microporation, accessed: July, 2015.